ВОПРОСЫ АДИПОКИНОВОЙ РЕГУЛЯЦИИ ПРИ ИДИОПАТИЧЕСКОЙ ЛЕГОЧНОЙ ГИПЕРТЕНЗИИ И СИСТЕМНОЙ ОСТЕОПЕНИИ
https://doi.org/10.18087/cardio.2018.2.10078
Аннотация
Об авторах
Е. А. Кочеткова
ФГБОУ ВО «Тихоокеанский государственный медицинский университет» Минздрава РФ
Россия
Россия
В. А. Невзорова
ФГБОУ ВО «Тихоокеанский государственный медицинский университет» Минздрава РФ
Россия
Россия
Л. Г. Угай
ФГБОУ ВО «Тихоокеанский государственный медицинский университет» Минздрава РФ
Россия
Россия
Ю. В. Майстровская
ФГБОУ ВО «Тихоокеанский государственный медицинский университет» Минздрава РФ
Россия
Россия
Т. А. Бродская
ФГБОУ ВО «Тихоокеанский государственный медицинский университет» Минздрава РФ
Россия
Россия
Список литературы
1. Lourenco A., Fontoura D., Henriques-Coelho T. et al. Current pathophysiological concepts and management of pulmonary hypertension. Int J Cardiol 2012;155:350-361. doi: 10.1016/ j. ijcard. 2011.05.066
2. Kochetkova E. A., Ugay L. G., Maystrovskaya Yu. V. et al. New mechanisms of osteoporosis formation in case of terminal lung disease. Pacific Medical J 2013;4:72-75.
3. Uzum A. K., Aydin M. M., Tutuncu Yi. et al. Serum grelin and adipinectin are increased but serum leptin level is unchanged in low weight Chronic Obstructive Pulmonary Disease patients. Eur J Internal Medicine 2014;25:364-369. doi: 10.1016/j. ejim. 2013.02.012
4. Sumino H., Ichikawa S., Kasama S. et al. Relationship between brachial arterial endothelial function and lumbar spine bone mineral density in postmenopausal women. Circ J 2007;71:1555-1559.
5. Alangiakrishman K., Juby A., Hanley D. et al. Role of vascular factors in osteoporosis. J Gerontol 2003;58:362-366.
6. Galiè N., Humbert M., Vachiery J. L. et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International S ociety for Heart and Lung Transplantation (iSHLt). Eur Heart J 2016;37 (1):67-119.
7. Nakanishi K., Takeda Y., Tetsumoto S. et al. Involvement of endothelial apoptosis underlying chronic obstructive pulmonary disease-like phenotype in adiponectin-null mice. Implications for therapy. Am J Respir Crit Care Med 2011;183:1164-1175. doi: 10.1164/rccm. 201007-1091OC
8. Tschopp O., Schmid C., Speich R. et al. Pretransplantation bone disease in patients with primary pulmonary hypertension. Chest 2006;129:1002-1008.
9. Malik N., McCarthy K., Minai O. A. Prevalence and significance of decreased bone density in pulmonary arterial hypertension. South Med J 2012;105 (7):344-9. doi: 10.1097/SMJ. 0b013e31825b8117
10. Vondracek S. F., Voelkel N. F., McDermott M. T., Valdez C. The relationship between adipokines, body composition, and bone density in men with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2009;4:267-277.
11. Zheng Y., Ma A., Wang Q. et al. Relation of leptin, ghrelin and inflammatory cytokines with body mass index in pulmonary tuberculosis patients with and without type 2 diabetes mellitus. PLoS One 2013;8 (11):e80122. http://dx.doi.org/10.1371/journal. pone. 0080122
12. Pobeha P., Ukropec J., Skyba P. et al. Relationship between osteoporosis and adipose tissue leptin and osteoprotegerin in patients with chronic obstructive pulmonary disease. Bone 2011;48 (5):1008-1014. doi: 10.1016/j. bone. 2011.02.017
13. Summer R., Fiack C. A., Ikeda Y. et al. Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease. Am J Physiol Lung Cell Mol Physiol 2009;297: L432 - L438. doi: 10.1152/ajplung. 90599.2008
14. Kistorp C., Faber J., Galatius S. et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005;112:1756-1762.
15. Santos M., Reis A., Gonçalves F. et al. Adiponectin levels are elevated in patients with pulmonary arterial hypertension. Clin Cardiol 2014;37 (1):21-25. doi: 10.1002/clc. 22210.
16. Huertas A., Tu L., Gambaryan N. et al. Leptin and regulatory Tlymphocytes in idiopathic pulmonary arterial hypertension. Eur Respir J 2012;40:895-904.
17. Mohiti-Ardekani J., Soleymani-Salehabadi H., Owlia M. B., Mohiti A. Relationships between serum adipocyte hormones (adiponectin, leptin, resistin), bone mineral density and bone metabolic markers in osteoporosis patients. J Bone Miner Metab 2014;32:400-404. doi: 10.1007/s00774-013-0511-4
18. Julia C., Czernichow S., Charnaux N. et al. Relationships between adipokines, biomarkers of endothelial function and inflammation and risk of type 2 diabetes. Diabetes Res Clin Pract 2014;105 (2):231-238. doi: 10.1016/j. diabres. 2014.05.001
19. Benza R. L., Gomberg-Maitland M., Demarco T. et al. Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med 2015;192 (11):1345-1354. doi: 10.1164/rccm. 201501-0196OC
20. Delgado-Frias E., López-Mejias R., Genre F. et al. Relationship between endothelial dysfunction and osteoprotegerin, vitamin D, and bone mineral density in patients with rheumatoid arthritis. Clin Exp Rheumatol 2015;33 (2):241-249.
21. Serizawa K., Yogo K., Tashiro Y. et al. Eldecalcitol prevents endothelial dysfunction in postmenopausal osteoporosis model rats. J Endocrinol 2016;228 (2):75-84. doi: 10.1530/JOE-15-0332.
22. Mestek M. L., Weil B. R., Greiner J. J. et al. Osteopenia and endothelin-1-mediated vasconstrictor tone in postmenopausal women. Bone 2010;47 (3):542-545. doi: 10.1016/j. bone. 2010.05.041.
23. Funada Y., Nishimura Y., Youkoyama M. Imbalance of matrix metal-loproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 is associated with pulmonary emphysema in Klotho mice. Kobe J Med Sci 2004;50:59-67.
24. Prasad M., Reriani M., Khosla S. et al. Coronary microvascular endothelial dysfunction is an independent predictor of development of osteoporosis in postmenopausal women. Vasc Health Risk Manag 2014;10:533-538. doi: 10.2147/VHRM. S63580.
25. Madonna R., Novo G., Balistreri C. R. Cellular and molecular basis of the imbalance between vascular damage and repair in aging and age-related diseases: As biomarkers and targets for new treatments. Mech Ageing Dev 2016 Mar 15. pii: S0047-6374 (16) 30026-4. doi: 10.1016/j. mad. 2016.03.005.
26. Withers S. B., Bussey C. E., Saxton S. N. et al. Mechanisms of adiponectin-associated perivascular function in vascular disease. Arterioscler Thromb Vasc Biol 2014;34 (8):1637-1642. doi: 10.1161 / AT VBAHA. 114.303031.
27. Oda A., Taniguchi T., Yokoyama M. Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci 2001;47:141-150.
Рецензия
Для цитирования:
Кочеткова Е.А., Невзорова В.А., Угай Л.Г., Майстровская Ю.В., Бродская Т.А. ВОПРОСЫ АДИПОКИНОВОЙ РЕГУЛЯЦИИ ПРИ ИДИОПАТИЧЕСКОЙ ЛЕГОЧНОЙ ГИПЕРТЕНЗИИ И СИСТЕМНОЙ ОСТЕОПЕНИИ. Кардиология. 2018;58(2):17-23. https://doi.org/10.18087/cardio.2018.2.10078
For citation:
Kochetkova E.A., Nevsorova V.A., Ugay L.G., Maystrovskaya Y.V., Brodskaya T.A. Issues of Adipokine Regulation in Idiopathic Pulmonary Arterial Hypertension and Systemic Osteopenia. Kardiologiia. 2018;58(2):17-23. (In Russ.) https://doi.org/10.18087/cardio.2018.2.10078
Просмотров: 661
Послать статью по эл. почте 
Оставить комментарий 
